✦ LIBER ✦

PDB19: THE COST-EFFECTIVENESS OF TARKA FOR PREVENTING RENAL FAILURE IN TYPE 2 DIABETIC PATIENTS WITH HYPERTENSION IN THE US HEALTH CARE SETTING

✍ Scribed by M Nuijten; W Wittenberg; J Kosa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV33 THE COST-EFFECTIVENESS OF TARKA IN

✍ M Nuijten; W Wittenberg; P Engelfriet; P Engelfriet 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PDB52 Cost-Effectiveness of Renal Screen

✍ T.W. Lung; A.J. Hayes; P.M. Clarke; R.J. Stevens; A. Farmer 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV32 COST-EFFECTIVENESS OF IRBESARTAN I

✍ H Hernandez; L Lepe; A Gonzalez; A Lemus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PDB44 COST-EFFECTIVENESS OF THE USE OF A

✍ S Ikeda; M Kobayashi; H Makino 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PDB17 THE HEALTH CARE COSTS OF LONG-ACTI

✍ J Gundgaard; T Christensen; TL Thomsen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PDB11 LONG-TERM COST-EFFECTIVENESS ANALY

✍ J Ray; AS Brandt; V Foos; V Munro; WJ Valentine; S Roze; AJ Palmer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB